Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LEGN

Legend Biotech Corp ADR

May 14 • 02:49PM ET

28.45

-0.22 -0.77 %

Healthcare • Biotechnology • USA • Mid • NASD

May 12, 1:33 PMLegend Biotech Q1 revenue $305M driven by CARVYKTI sales +52% YoY, nears adjusted profitability despite temporary gross margin hit

Peers: ALLO IOVA JANX CRSP FATE

| Held by: IBB IEMG IXUS CANC MCHI EEM KOMP FBCG SPEM GNOM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.36	Insider Own	3.65%	Shs Outstand	185.74M	Perf Week	-0.42%
Market Cap	5.26B	Forward P/E	31.01	EPS next Y	0.92	Insider Trans	-0.15%	Shs Float	178.20M	Perf Month	38.65%
Enterprise Value	4.82B	PEG	-	EPS next Q	0.05	Inst Own	44.79%	Short Float	9.54%	Perf Quarter	57.53%
Income	-250.98M	P/S	4.61	EPS this Y	112.17%	Inst Trans	2.64%	Short Ratio	8.05	Perf Half Y	-11.18%
Sales	1.14B	P/B	5.46	EPS next Y	830.77%	ROA	-15.63%	Short Interest	17.00M	Perf YTD	30.86%
Book/sh	5.21	P/C	6.30	EPS next 5Y	-	ROE	-25.28%	52W High	45.30 -37.19%	Perf Year	2.34%
Cash/sh	4.51	P/FCF	-	EPS past 3/5Y	16.80% 6.49%	ROIC	-23.24%	52W Low	16.24 75.18%	Perf 3Y	-59.51%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	106.67% 68.87%	Gross Margin	51.52%	Volatility	9.75% 8.41%	Perf 5Y	-3.89%
Dividend TTM	-	EV/Sales	4.22	EPS Y/Y TTM	-66.81%	Oper. Margin	-11.57%	ATR (14)	1.88	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.05	Sales Y/Y TTM	56.94%	Profit Margin	-21.97%	RSI (14)	65.35	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	2.13	EPS Q/Q	46.50%	SMA20	10.70%	Beta	0.35	Target Price	55.64
Payout	-	Debt/Eq	0.40	Sales Q/Q	56.66%	SMA50	33.23%	Rel Volume	0.85	Prev Close	28.67
Employees	2900	LT Debt/Eq	0.12	Earnings	May 12 BMO	SMA200	7.80%	Avg Volume	2.11M	Price	28.45
IPO	Jun 05, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-1319.51% -0.46%	Trades		Volume	1,485,616	Change	-0.77%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-12-26	Downgrade	Rothschild & Co Redburn	Buy → Neutral	$24
Jan-22-26	Downgrade	TD Cowen	Buy → Hold	$21
Jan-07-26	Initiated	Oppenheimer	Outperform	$75
Oct-07-25	Initiated	Cantor Fitzgerald	Overweight	$40
Oct-08-24	Initiated	Redburn Atlantic	Buy	$86
Jun-17-24	Initiated	Truist	Buy	$88
May-24-24	Reiterated	H.C. Wainwright	Buy	$86 → $73
May-23-24	Initiated	Deutsche Bank	Buy	$60
Apr-17-24	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$65
Apr-03-24	Initiated	Cantor Fitzgerald	Overweight	$82
Mar-13-24	Initiated	Raymond James	Outperform	$86
Dec-19-23	Initiated	Scotiabank	Sector Perform
Nov-06-23	Initiated	Goldman	Buy	$90.09
May-25-23	Initiated	William Blair	Mkt Perform	$64
May-22-23	Initiated	Daiwa Securities	Buy
Mar-29-23	Initiated	H.C. Wainwright	Buy	$66
Mar-24-23	Initiated	RBC Capital Mkts	Outperform	$73
Dec-06-22	Initiated	UBS	Buy	$66
Nov-02-22	Initiated	Evercore ISI	Outperform
Nov-01-22	Initiated	Cowen	Outperform

Show Previous Ratings

May-12-26 03:00PM	Legend Biotech Corp (LEGN) Q1 2026 Earnings Call Highlights: Strong CARVYKTI Sales and ... (GuruFocus.com) +10.48%
07:00AM	Legend Biotech Reports First Quarter 2026 Results and Recent Highlights (GlobeNewswire)
May-04-26 08:00AM	Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth (GlobeNewswire) +12.34%
Apr-28-26 08:00AM	Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results (GlobeNewswire)
Mar-25-26 01:10PM	Johnson & Johnson Exits 3 Biotechs but Keeps Stakes in These Rumored Acquisition Targets (Barrons.com)
03:00AM	Loading…
Mar-16-26 03:00AM	Genscript Biotech Corp (GNNSF) Full Year 2025 Earnings Call Highlights: Record Revenue Growth ... (GuruFocus.com)
Mar-10-26 03:00PM	Legend Biotech Corp (LEGN) Q4 2025 Earnings Call Highlights: Record Growth and Profitability ... (GuruFocus.com)
07:00AM	Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights (GlobeNewswire)
Feb-24-26 08:00AM	Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results (GlobeNewswire)
Feb-18-26 02:04AM	Barclays Cite Favorable Long-Term Outlook For Legend Biotech Corporation (LEGN) Despite Near-Term Expectation Revisions (Insider Monkey)
Feb-16-26 12:24PM	FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN) (Insider Monkey)
Feb-07-26 03:33AM	Legend Biotech (LEGN) Shakes Up Board (Insider Monkey)
Feb-02-26 09:38AM	H.C. Wainwright Highlight Curative Potential of Legend Biotech Corporation (LEGN)'s Carvykti Despite Sales Miss (Insider Monkey)
Jan-26-26 03:14AM	Legend Biotech (LEGN) Advances Cell Therapy Innovation and Expands Oncology Pipeline (Insider Monkey)
Jan-22-26 08:00AM	Here Are Thursdays Top Wall Street Analyst Research Calls: Alphabet, Callaway Golf, Datadog, Hyatt Hotels, Palantir, Texas Instruments, Verizon, and More (24/7 Wall St.) -6.84%
08:00AM	Loading…
Jan-21-26 08:00AM	Legend Biotech to Present CARVYKTI Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use (GlobeNewswire) -11.36%
Jan-12-26 08:00AM	Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-09-26 03:16AM	Cantor Fitzgerald and RBC Capital Stay Bullish on Legend Biotech (LEGN) (Insider Monkey)
Dec-22-25 06:50AM	Here is Why Legend Biotech (LEGN) Offers Such Promising Upside (Insider Monkey)
Dec-17-25 08:00AM	Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-11-25 07:44AM	Legend Biotech Corporation (LEGN) is an Outperform on Multiple Myeloma Treatment CARVYKTI Prospects (Insider Monkey)
Dec-09-25 03:31PM	Cancer Study Buoys These Small Biotechs (Barrons.com) -8.58%
Dec-06-25 02:00PM	Legend Biotech Highlights New CARVYKTI Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025 (GlobeNewswire)
Nov-27-25 09:00AM	Legend Biotech Awarded 2025 FIBA Foreign Investor of the Year by Flanders Investment & Trade (GlobeNewswire)
Nov-25-25 08:39AM	William Blair Maintains Hold Rating on Legend Biotech (LEGN) Despite Carvykti Label Safety Concerns (Insider Monkey)
Nov-13-25 12:08PM	Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia (GlobeNewswire)
09:21AM	Company News for Nov 13, 2025 (Zacks)
Nov-12-25 02:03PM	Legend Biotech Corp (LEGN) Q3 2025 Earnings Call Highlights: Record CARVYKTI Sales and ... (GuruFocus.com)
07:00AM	Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights (GlobeNewswire)
Nov-10-25 08:16PM	H.C. Wainwright Remains Bullish on Legend Biotech (LEGN), Cites Solid Growth Trajectory for CARVYKTI Therapy (Insider Monkey)
11:05AM	Loading…
Nov-03-25 11:05AM	Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting (GlobeNewswire)
Oct-29-25 08:00AM	Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results (GlobeNewswire)
Oct-21-25 09:15AM	CorMedix (CRMD) Surges 19.5%: Is This an Indication of Further Gains? (Zacks)
Oct-17-25 09:54PM	J.P. Morgan Maintains a Buy on Legend Biotech Corporation (LEGN) (Insider Monkey)
Oct-08-25 12:57AM	TD Cowen Reiterates a Buy Rating on Legend Biotech Corporation (LEGN) (Insider Monkey)
Sep-30-25 04:00AM	RBC Capital Reiterates a Buy Rating on Legend Biotech Corporation (LEGN) (Insider Monkey)
Aug-26-25 08:00AM	Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference (GlobeNewswire)
Aug-22-25 11:57PM	RBC Capital Lifts PT on Legend Biotech Corporation (LEGN) to $77 From $75 (Insider Monkey)
05:30AM	China's rise in biotech to potentially lower healthcare costs, life science investor says (South China Morning Post)
Aug-18-25 08:00AM	Legend Biotech Appoints Carlos Santos as Chief Financial Officer (GlobeNewswire)
Aug-12-25 07:22AM	Company News for Aug 12, 2025 (Zacks)
03:03AM	Legend Biotech Corp (LEGN) Q2 2025 Earnings Call Highlights: Record CARVYKTI Sales and ... (GuruFocus.com)
Aug-11-25 10:53AM	Key Inflation Data in Focus (Zacks)
10:12AM	Pre-Markets in Green, Inflation Data, Retail Sales, Q2 Earnings This Week (Zacks)
07:00AM	Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights (GlobeNewswire)
Aug-08-25 09:17AM	Legend Biotech Corp (LEGN) Q2 2025 Earnings Report Preview: What to Expect (GuruFocus.com)
Jul-28-25 08:00AM	Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results (GlobeNewswire)
Jul-18-25 07:24AM	Legend Biotech (LEGN) Surges 6.0%: Is This an Indication of Further Gains? (Zacks)
Jul-13-25 05:00PM	China Biotechs Stunning Advance Is Changing the Worlds Drug Pipeline (Bloomberg)
Jul-06-25 04:15AM	H.C. Wainwright Maintains a Buy on Legend Biotech (LEGN) With a $75 Price Target (Insider Monkey)
Jun-20-25 04:08PM	The FDA Shake-Up Continues, And Could Impact Genetic Medicines (Investor's Business Daily)
Jun-03-25 10:45AM	Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI in Multiple Myeloma at 2025 ASCO Annual Meeting (GlobeNewswire)
May-22-25 05:15PM	Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT (GlobeNewswire)
May-19-25 08:00AM	Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
May-14-25 09:18AM	Morning Movers: UnitedHealth sinks following CEO exit and outlook suspension (TipRanks) -10.55%
03:06AM	Legend Biotech Corp (LEGN) Q1 2025 Earnings Call Highlights: Record Growth in CARVYKTI Sales ... (GuruFocus.com)
12:24AM	Q1 2025 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
May-13-25 07:00AM	Legend Biotech Reports First Quarter 2025 Results and Recent Highlights (GlobeNewswire)
May-12-25 09:20AM	What To Expect From Legend Biotech Corp (LEGN) Q1 2025 Earnings (GuruFocus.com)
May-03-25 04:51AM	The Play On Legend Biotech (Seeking Alpha)
May-02-25 12:00PM	What Makes Legend Biotech (LEGN) a New Buy Stock (Zacks)
09:55AM	Wall Street Analysts Think Legend Biotech (LEGN) Could Surge 135.16%: Read This Before Placing a Bet (Zacks)
Apr-29-25 08:00AM	Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results (GlobeNewswire)
Apr-24-25 06:53AM	Legend Biotech Corporation (LEGN): Among Takeover Rumors Hedge Funds Are Buying (Insider Monkey)
Apr-16-25 09:53AM	Legend Biotech (LEGN) Moves 5.1% Higher: Will This Strength Last? (Zacks)
Apr-11-25 12:30AM	Harbor Health Care ETF Q4 2024 Commentary (Seeking Alpha)
Apr-09-25 05:53AM	Pacira (PCRX) Surges 14.7%: Is This an Indication of Further Gains? (Zacks)
Apr-01-25 11:50AM	Biotech stocks slide as Marks resignation seen being negative for sector (TipRanks) -7.10%
Mar-12-25 03:02AM	Legend Biotech Corp (LEGN) Q4 2024 Earnings Call Highlights: Record CARVYKTI Sales and ... (GuruFocus.com)
01:34AM	Q4 2024 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
Mar-11-25 09:30AM	Compared to Estimates, Legend Biotech (LEGN) Q4 Earnings: A Look at Key Metrics (Zacks) +9.29%
07:00AM	Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights (GlobeNewswire)
Feb-25-25 08:00AM	Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results (GlobeNewswire)
Feb-23-25 01:29PM	Why Legend Biotech Corporation (LEGN) is the Most Oversold Pharma Stock to Buy According to Analysts (Insider Monkey)
Feb-21-25 09:43AM	Market Concerns Put Pressure on Legend Biotech Corporation (LEGN) Shares (Insider Monkey)
Feb-20-25 12:18PM	Legend Biotech Corporation (LEGN): One of the Most Oversold Healthcare Stocks to Buy Now (Insider Monkey)
Feb-13-25 02:06PM	Is Legend Biotech (LEGN) the Best Mid-Cap Growth Stock to Buy According to Analysts? (Insider Monkey)
Feb-08-25 09:29AM	Why Legend Biotech Corporation (LEGN) Is Among the Best Healthcare Stocks To Buy According to Analysts (Insider Monkey)
Jan-30-25 05:01PM	Heres Why Legend Biotech Corporation (LEGN) Will Double in 2025 (Insider Monkey)
Jan-17-25 11:04AM	Legend Biotech Corporation (LEGN): The Biotech Stock with Biggest Upside Potential (Insider Monkey)
Dec-19-24 08:01AM	Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-11-24 07:22AM	Legend Biotechs CARVYKTI® Boosts Myeloma Treatment Success (TipRanks) -5.44%
Dec-09-24 07:35PM	CARVYKTI Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma (GlobeNewswire) -8.96%
04:22PM	Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead. (Investor's Business Daily)
Nov-27-24 10:02AM	Why Is Legend Biotech Corp. (LEGN) Among the Best Up and Coming Stocks to Buy According to Analysts? (Insider Monkey)
Nov-22-24 07:31AM	Legend Biotech Corp. (LEGN): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts (Insider Monkey)
Nov-21-24 05:28PM	Why Is Legend Biotech Corporation (LEGN) Among the Worst Performing Biotech Stocks in 2024? (Insider Monkey)
Nov-13-24 03:28AM	Q3 2024 Legend Biotech Corp Earnings Call (Thomson Reuters StreetEvents)
02:07AM	Legend Biotech Corp (LEGN) Q3 2024 Earnings Call Highlights: CARVYKTI's Impressive Growth Amid ... (GuruFocus.com)
Nov-12-24 09:30AM	Legend Biotech (LEGN) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
07:00AM	Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights (GlobeNewswire)
Nov-11-24 09:55AM	Legend Biotech (LEGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks)
07:04AM	Legend Biotech Corp (LEGN) Q3 2024 Earnings Report Preview: What to Look For (GuruFocus.com)
Nov-07-24 07:30AM	Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition (GlobeNewswire)
Nov-05-24 09:10AM	Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma (GlobeNewswire)
Nov-04-24 07:30AM	Legend Biotech Appoints Alan Bash as President of CARVYKTI (GlobeNewswire)
Oct-24-24 09:55AM	Wall Street Analysts Believe Legend Biotech (LEGN) Could Rally 90.83%: Here's is How to Trade (Zacks)
08:00AM	Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results (GlobeNewswire)
Oct-16-24 03:45PM	Is Legend Biotech Corporation (LEGN) the Most Promising Biotech Stock According to Hedge Funds? (Insider Monkey)
Oct-03-24 07:30AM	Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia (GlobeNewswire)

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Huang Ying	Chief Executive Officer	Mar 25 '26	Sale	8.77	9,936	87,139	247,438	Mar 27 04:25 PM
Huang Ying	Officer	Mar 26 '26	Proposed Sale	17.54	4,968	87,149		Mar 26 04:27 PM
Yeung Jessie	Officer	Mar 26 '26	Proposed Sale	17.54	1,862	32,663		Mar 26 04:20 PM
Huang Ying	Officer	Dec 26 '25	Proposed Sale	22.52	64,339	1,449,074		Dec 29 07:28 AM
Sanders Corazon (Corsee) D.	Director	Dec 24 '25	Proposed Sale	22.77	969	22,064		Dec 29 06:45 AM
Huang Ying	Officer	Dec 24 '25	Proposed Sale	22.95	61,467	1,410,606		Dec 29 06:40 AM
GenScript Corporation	Affiliate	Nov 17 '25	Proposed Sale	30.29	203,586	6,166,620		Nov 17 05:50 PM
Casey Patrick John	Director	Sep 26 '25	Proposed Sale	33.28	1,000	33,285		Sep 26 04:24 PM
Huang Ying	Officer	Sep 24 '25	Proposed Sale	33.00	1,370	45,210		Sep 24 10:02 AM
Huang Ying	Officer	Sep 23 '25	Proposed Sale	33.98	1,357	46,112		Sep 23 03:13 PM
Yeung Jessie	Officer	Sep 23 '25	Proposed Sale	33.98	474	16,107		Sep 23 03:13 PM
Sanders Corazon (Corsee) D.	Director	Sep 23 '25	Proposed Sale	34.00	307	10,438		Sep 23 09:47 AM
Huang Ying	Officer	Jul 23 '25	Proposed Sale	45.04	15,291	688,723		Jul 23 04:11 PM
Yeung Jessie	Officer	Jul 23 '25	Proposed Sale	45.00	642	28,890		Jul 23 12:00 PM
Casey Patrick John	Director	Jun 26 '25	Proposed Sale	33.23	1,000	33,234		Jun 26 11:21 AM
Huang Ying	Officer	Jun 25 '25	Proposed Sale	33.72	12,119	408,653		Jun 25 10:31 AM
Huang Ying	Officer	Jun 24 '25	Proposed Sale	34.60	11,810	408,600		Jun 24 04:23 PM
Sanders Corazon (Corsee) D.	Director	Jun 24 '25	Proposed Sale	34.37	307	10,552		Jun 24 10:05 AM
Casey Patrick John	Director	Jun 06 '25	Proposed Sale	32.32	1,000	32,320		Jun 06 11:18 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LEGN

Legend Biotech Corp ADR

Upgrade your Finviz experience